Studies in animal models documented beneficial effects from FXR activation by specific agonists as INT-747 [11], fexaramine [197], and GW4064 [198] documented by prevention of colitis, anti-inflammatory effects, restored BA homeostasis, and gut microbiota modulation. Here, NR1H4 is linked to colitis.